Evidence map›Paper›PMID 32641657›Full record

ReviewInternal medicine (Tokyo, Japan)2020

Adult T-cell Leukemia-lymphoma with Primary Breast Involvement: A Case Report and Literature Review.

Hiroki Kobayashi, Noboru Asada, Takuro Igawa, Masaya Abe, Yusuke Meguri, Daisuke Ennishi, Hisakazu Nishimori, Nobuharu Fujii, Ken-Ichi Matsuoka, Tadashi Yoshino and 1 more

Open access · diamondAbstract readCase ReportsReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Internal medicine (Tokyo, Japan), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.1field-weighted citation impact, top 58% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 2 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Hiroki KobayashiDepartment of Hematology and Oncology, Okayama University Hospital, Japan.
Noboru AsadaDepartment of Hematology and Oncology, Okayama University Hospital, Japan.
Takuro IgawaDepartment of Pathology, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, Japan.
Masaya AbeDepartment of Hematology and Oncology, Okayama University Hospital, Japan.
Yusuke MeguriDepartment of Hematology and Oncology, Okayama University Hospital, Japan.
Daisuke EnnishiDepartment of Hematology and Oncology, Okayama University Hospital, Japan.
Hisakazu NishimoriDepartment of Hematology and Oncology, Okayama University Hospital, Japan.
Nobuharu FujiiDepartment of Transfusion Medicine, Okayama University Hospital, Japan.
Ken-Ichi MatsuokaDepartment of Hematology and Oncology, Okayama University Hospital, Japan.
Tadashi YoshinoDepartment of Pathology, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, Japan.
Yoshinobu MaedaDepartment of Hematology and Oncology, Okayama University Hospital, Japan.
Okayama University Hospital · JPOkayama University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Breast involvement of Adult T-cell leukemia-lymphoma (ATLL) is extremely rare, and the data on the characteristics are limited. We herein describe a 49-year-old woman who presented with skin involvement of ATLL. Positron emission tomography/computed tomography showed bilateral breast lesions. Although the patient once achieved a complete metabolic response, a relapse of her ATLL occurred. The patient received subsequent allogeneic hematopoietic stem cell transplantation (HSCT). To our knowledge, only four cases of ATLL with breast involvement have previously been reported, and the prognoses have generally been poor. Breast lesions of ATLL have aggressive features, and intensive systemic chemotherapy and HSCT are required to improve survival.

Indexed as

AgedAged, 80 and overAntineoplastic AgentsBreast NeoplasmsFemaleHematopoietic Stem Cell TransplantationHumansJapanLeukemia-Lymphoma, Adult T-CellMiddle AgedPrognosisTreatment OutcomeAntineoplastic Agentsadult T-cell leukemia-lymphomabreast involvementpositron emission tomography/computed tomography

Identifiers

PMID32641657
PMCPMC7691018
OpenAlexW3038595207

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.